News and Announcements
Proteomics International Laboratories Appoints New Director
- Published October 19, 2015 11:59AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
16th October 2015, ASX Announcement
Life science company Proteomics International Laboratories Ltd (ASX: PIQ) (the Company, PILL) is pleased to announce the appointment of Mr James Moses to the Company’s board as an executive director, effective form today.
Mr Moses has extensive experience in investment markets and the media developed in a career spanning 25 years, including a wealth of expertise in advising emerging small-cap public companies.
He will work closely with the Company’s leadership team to develop and implement appropriate strategies to maximise PILL’s awareness and penetration in investment markets and with external stakeholders.
To read the full announcement, please click here.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
